A. ÖZKAYA Et Al. , "The real life data of ranibizumab use among the diabetic macular edema patients in Turkey: Documenting the improvement with clinical optimization during three consecutive years," SAUDI JOURNAL OF OPHTHALMOLOGY , vol.32, no.3, pp.175-179, 2018
ÖZKAYA, A. Et Al. 2018. The real life data of ranibizumab use among the diabetic macular edema patients in Turkey: Documenting the improvement with clinical optimization during three consecutive years. SAUDI JOURNAL OF OPHTHALMOLOGY , vol.32, no.3 , 175-179.
ÖZKAYA, A., ÖZVEREN, M., & DEMİRCAN, A., (2018). The real life data of ranibizumab use among the diabetic macular edema patients in Turkey: Documenting the improvement with clinical optimization during three consecutive years. SAUDI JOURNAL OF OPHTHALMOLOGY , vol.32, no.3, 175-179.
ÖZKAYA, ABDULLAH, MEHMET ÖZVEREN, And Ali DEMİRCAN. "The real life data of ranibizumab use among the diabetic macular edema patients in Turkey: Documenting the improvement with clinical optimization during three consecutive years," SAUDI JOURNAL OF OPHTHALMOLOGY , vol.32, no.3, 175-179, 2018
ÖZKAYA, ABDULLAH Et Al. "The real life data of ranibizumab use among the diabetic macular edema patients in Turkey: Documenting the improvement with clinical optimization during three consecutive years." SAUDI JOURNAL OF OPHTHALMOLOGY , vol.32, no.3, pp.175-179, 2018
ÖZKAYA, A. ÖZVEREN, M. And DEMİRCAN, A. (2018) . "The real life data of ranibizumab use among the diabetic macular edema patients in Turkey: Documenting the improvement with clinical optimization during three consecutive years." SAUDI JOURNAL OF OPHTHALMOLOGY , vol.32, no.3, pp.175-179.
@article{article, author={ABDULLAH ÖZKAYA Et Al. }, title={The real life data of ranibizumab use among the diabetic macular edema patients in Turkey: Documenting the improvement with clinical optimization during three consecutive years}, journal={SAUDI JOURNAL OF OPHTHALMOLOGY}, year=2018, pages={175-179} }